Orshe

Two GSK execs were asked to quit the nonprofit’s board after the drug maker learned it was selling resveratrol supplements.

See the rest here: GlaxoSmithKline Tells Execs to Leave Nonprofit Selling Resveratrol Supplements

Aetna Chairman and CEO Ronald Williams discusses the recent partnership between Aetna and CVS Caremark in an interview with WSJ Deputy Managing Editor Alan Murray.

See more here:  Aetna CEO: CVS Partnership Good for Shareholders/a>

What’s responsible for the age-related performance declines seen in most sports?

See more here: What Does Aging Mean for Elite Athletes? (Lance, We Mean You)

Also: legal battles over health-care overhaul begin; AstraZeneca gets fined by an E.U. court; excess swine flu vaccine stocks headed for the trash.

Read the rest here: A.M. Vitals: A Genetic Test Pegging the Odds of Living Past 100

Until this month, there wasn’t much solid evidence that HGH improves aspects of athletic performance.

Read more:  Does Human Growth Hormone Actually Do Anything for Athletes?

A small GlaxoSmithKline trial of a drug called SRT501, a rejiggered version of resveratrol, has been halted on safety concerns.

Go here to read the rest:  Is the Bloom Off the Resveratrol Rose?

Skin types at the fair end of the spectrum are more susceptible to the burning rays of the sun — and to a higher risk for cancers and premature aging of the skin. But a little sun exposure also releases endorphins and gives us needed vitamin D. WSJ’s Melinda Beck and Laura Landro debate how good or bad the sun is for you on the News Hub.

Read the original post:  News Hub: The Sun and Your Health/a>

Agents of the Drug Enforcement Administration have been pushing harder to investigate cases of nursing-home staff giving powerful medications to patients without a doctor’s prescription. But if that sounds all well and good, some say it’s just the nub of a more-complicated situation.

It took 14 months of birthing — and there’s still a ittle ground to go before it’s all official — but the health-care overall is effective here. The opinions about what it all means remained mixed, but whether they were for or against the legislation, many health-care groups say they are focused now on trying to improve what they see as flaws. Here are some of extracts from of statements:

Consumer demand for innovation and customization, a boon for new entrants such as Beachbody and CrossFit, could spur capital markets activity in the sector, says Joe Pellegrini, managing director of Robert W. Baird’s consumer investment banking group.

Read more from the original source: Content Spurs Changes In U.S. Fitness Sector/a>